Zai Lab (ZLAB) Gross Profit (2019 - 2026)
Zai Lab (ZLAB) posted Gross Profit of $61.3 million for Q1 2026, down 6.13% sequentially from $65.3 million in Q4 2025, and down 9.91% YoY from $68.0 million in Q1 2025.
Zai Lab (ZLAB) Gross Profit (2019 - 2026) Analysis & Trends
Zai Lab has reported Gross Profit for 8 years, with the latest figure at $61.3 million in Q1 2026.
- Quarterly Gross Profit fell 9.91% year-over-year to $61.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $262.9 million (down 1.31% YoY) and the FY2025 annual result came in at $269.6 million, up 7.05% from the prior year.
- Gross Profit declined to $61.3 million in Q1 2026 per ZLAB's latest filing, from $65.3 million in the prior quarter.
- Over five years, Gross Profit peaked at $69.3 million in Q3 2025 and troughed at $30.8 million in Q2 2022.
- A 5-year average of $52.6 million and a median of $53.5 million in 2024 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2022 and 2026: Gross Profit soared 146.71% in 2022, then decreased 9.91% in 2026.
- Over 5 years, Gross Profit stood at $41.7 million in 2022, then retreated by 2.6% to $40.6 million in 2023, then surged by 65.76% to $67.3 million in 2024, then declined by 2.96% to $65.3 million in 2025, then declined by 6.13% to $61.3 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $61.3 million, $65.3 million, and $69.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.15 Mn |
| Jun 30, 2026 | 58.15 Mn |
| Mar 31, 2026 | 61.30 Mn |
| Mar 31, 2026 | 61.30 Mn |
| Dec 31, 2025 | 65.30 Mn |
| Dec 31, 2025 | 65.30 Mn |
| Sep 30, 2025 | 69.33 Mn |
| Sep 30, 2025 | 69.33 Mn |
| Jun 30, 2025 | 66.97 Mn |
| Jun 30, 2025 | 66.97 Mn |
| Mar 31, 2025 | 68.04 Mn |
| Mar 31, 2025 | 68.04 Mn |
| Dec 31, 2024 | 67.29 Mn |
| Dec 31, 2024 | 67.29 Mn |
| Sep 30, 2024 | 65.70 Mn |
| Sep 30, 2024 | 65.70 Mn |
| Jun 30, 2024 | 65.36 Mn |
| Jun 30, 2024 | 65.36 Mn |
| Mar 31, 2024 | 53.53 Mn |
| Mar 31, 2024 | 53.53 Mn |